docetaxel anhydrous has been researched along with Sex Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baciuchka, M; Berdah, JF; Beuzeboc, P; Bousquet, G; Dauba, J; Delva, R; Deplanque, G; El Kouri, C; Esterni, B; Eymard, JC; Ferrero, JM; Fizazi, K; Gravis, G; Habibian, M; Hasbini, A; Joly, F; Krakowski, I; Labourey, JL; Laguerre, B; Latorzeff, I; Linassier, C; Machiels, JP; Marino, P; Mourey, L; Oudard, S; Platini, C; Pouessel, D; Priou, F; Ravaud, A; Rolland, F; Soulie, M; Suc, E; Théodore, C; Zanetta, S | 1 |
1 trial(s) available for docetaxel anhydrous and Sex Disorders
Article | Year |
---|---|
Patients' self-assessment versus investigators' evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15).
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Arthralgia; Docetaxel; Fatigue; Hot Flashes; Humans; Male; Middle Aged; Neoplasm Metastasis; Outcome Assessment, Health Care; Physician-Patient Relations; Prostatic Neoplasms; Self-Assessment; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Taxoids; Weight Gain; Weight Loss | 2014 |